High materiality7/10
Arcus Biosciences price target raised to $40 from $35 at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist raises RCUS target to $40; current price $29.66.
- Target $40; Price $29.66; Firm: Truist Financial
Key facts
- 01
Target: $40
- 02
Posted price: $29.66
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.